Literature DB >> 26823771

Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model.

Renbin Yu1, Shunyu Xu2, Yanxia Wang3, Hengjuan Cai2, Ping Xu1.   

Abstract

BACKGROUND AND
OBJECTIVE: Human major histocompatibility complex class I-related gene A (MICA) is reportedly associated with poor transplant outcomes and a high risk of acute and chronic rejection in solid organ transplantation. However, studies on these risks have found conflicting results. In the present study, we investigate the MICA expression and serum MICA (sMICA) as well as the MICA antibodies (anti-MICA) in serum of recipients during acute rejection (AR) in a rat-to-mouse cardiac transplantation model.
METHODS: Construct rat-to-mouse concordant cardiac transplantation models, histological examination of the heart in recipients during AR at 2-6 hours time point was done. We then studied the MICA gene expression of the heart in recipients during AR at 2-6 hours time point by western blot and RT-PCR assay. We latter studied the anti-MICA and sMICA levels in serum of recipients during AR at 2-6 hours time point by Flow cytometry and ELISA measurement.
RESULTS: We found that Lewis rat hearts transplanted into BALB/c mice developed typical AR in 6 days. The level of severity of xenograft rejection from 2 d to 6 d was increased in a time-dependant way. MICA protein and MICA mRNA was also increased in time-dependant way and reached the highest value at 6 h. The prevalence of anti-MICA was significantly higher among those with severe acute rejection. However, sMICA was significantly increased during AR at 2 hours, then gradually decreased, and reached the lowest value at 6 h.
CONCLUSIONS: MICA expression in recipients' heart and anti-MICA antibodies in recipients' sera may associated with high risk of AR in rat-to-mouse transplantation. sMICA showed a negative association with acute rejection and may be a good predictor of heart transplant outcomes.

Entities:  

Keywords:  Cardiac xenograft; MICA; anti-MICA; heart acute rejection; sMICA

Mesh:

Substances:

Year:  2015        PMID: 26823771      PMCID: PMC4713557     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.

Authors:  B Suárez-Alvarez; A López-Vázquez; M Zapico Gonzalez; J L Fdez-Morera; B Díaz-Molina; M A Blanco-Gelaz; D Pascual; J Martínez-Borra; M Muro; M R Alvarez-López; C López-Larrea
Journal:  Am J Transplant       Date:  2007-05-19       Impact factor: 8.086

2.  Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures.

Authors:  Li Li; Persis Wadia; Rong Chen; Neeraja Kambham; Maarten Naesens; Tara K Sigdel; David B Miklos; Minnie M Sarwal; Atul J Butte
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

3.  MIC expression in renal and pancreatic allografts.

Authors:  Kim G Hankey; Cinthia B Drachenberg; John C Papadimitriou; David K Klassen; Benjamin Philosophe; Steven T Bartlett; Veronika Groh; Thomas Spies; Dean L Mann
Journal:  Transplantation       Date:  2002-01-27       Impact factor: 4.939

4.  MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies.

Authors:  Yizhou Zou; Fariba Mirbaha; Ana Lazaro; Yanzheng Zhang; Bhavna Lavingia; Peter Stastny
Journal:  Hum Immunol       Date:  2002-01       Impact factor: 2.850

5.  Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation.

Authors:  Dilip S Nath; Nataraju Angaswamy; Haseeb Ilias Basha; Donna Phelan; Nader Moazami; Gregory A Ewald; T Mohanakumar
Journal:  Hum Immunol       Date:  2010-09-21       Impact factor: 2.850

6.  HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.

Authors:  Medhat Askar; Eileen Hsich; Patrick Reville; Amy S Nowacki; William Baldwin; Suzanne Bakdash; Jenna Daghstani; Aiwen Zhang; Lynne Klingman; Nicholas Smedira; Nader Moazami; David O Taylor; Randall C Starling; Gonzalo Gonzalez-Stawinski
Journal:  J Heart Lung Transplant       Date:  2013-09-24       Impact factor: 10.247

7.  Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding.

Authors:  Helmut R Salih; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

8.  Frequency of MIC antibody in rejected renal transplant patients without HLA antibody.

Authors:  Kazuo Mizutani; Paul I Terasaki; Remi N J Shih; Rui Pei; Miyuki Ozawa; Jarhow Lee
Journal:  Hum Immunol       Date:  2006-03-31       Impact factor: 2.850

9.  Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.

Authors:  Yizhou Zou; Falko M Heinemann; Hans Grosse-Wilde; Guido Sireci; Zhengnan Wang; Bhavna Lavingia; Peter Stastny
Journal:  Hum Immunol       Date:  2006-03-30       Impact factor: 2.850

10.  BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

Authors:  Nicolas Boissel; Delphine Rea; Vannary Tieng; Nicolas Dulphy; Manuel Brun; Jean-Michel Cayuela; Philippe Rousselot; Ryad Tamouza; Philippe Le Bouteiller; François-Xavier Mahon; Alexander Steinle; Dominique Charron; Hervé Dombret; Antoine Toubert
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  3 in total

Review 1.  Immune monitoring as prerequisite for transplantation tolerance trials.

Authors:  K Behnam Sani; B Sawitzki
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

Review 2.  MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome?

Authors:  Matilde Risti; Maria da Graça Bicalho
Journal:  Front Immunol       Date:  2017-02-27       Impact factor: 7.561

Review 3.  Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation.

Authors:  Ajay Kumar Baranwal; Narinder K Mehra
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.